In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study

Autor: Meizi Kang, Jing Chen, Lingling Liu, Cheng Xue, Xiaojing Tang, Jiayi Lv, Lili Fu, Changlin Mei, Zhiguo Mao, Yawei Liu, Bing Dai

Publikováno v: Frontiers in Medicine, Vol 9 (2022)

Fibroblast growth factor 23(FGF23) is the most important biomarker and pathogenic factor in Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). In the moderate and severe stages of chronic renal failure, abnormally elevated circulating FG

Externí odkaz: https://doaj.org/article/f4f690bd4c1045a8827210319140cc4e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry

Autor: Eric Laruelle, Brigit C. van Jaarsveld, Kitty J Jager, Frederic Collart, Helena Rydell, Cécile Couchoud, Aleix Cases, Jamie P. Traynor, Thijs T. Jansz, Jaakko Helve, Mustafa Arici, Ziad A. Massy, Marlies Noordzij, Carmine Zoccali, Anneke Kramer, Bård Waldum-Grevbo

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2020, 35 (3), pp.488-495. ⟨10.1093/ndt/gfz208⟩
Jansz, T T, Noordzij, M, Kramer, A, Laruelle, E, Couchoud, C, Collart, F, Cases, A, Arici, M, Helve, J, Waldum-Grevbo, B, Rydell, H, Traynor, J P, Zoccali, C, Massy, Z A, Jager, K J & van Jaarsveld, B C 2020, ' Survival of patients treated with extended-hours haemodialysis in Europe : an analysis of the ERA-EDTA Registry ', Nephrology, Dialysis, Transplantation, vol. 35, no. 3, pp. 488-495 . https://doi.org/10.1093/ndt/gfz208
Nephrology, dialysis, transplantation, 35(3), 488-495. Oxford University Press
Nephrology, Dialysis, Transplantation, 35(3), 488-495. Oxford University Press
Nephrology Dialysis Transplantation, Oxford University Press, 2020, 35 (3), pp.488-495. ⟨10.1093/ndt/gfz208⟩

Background Previous US studies have indicated that haemodialysis with ≥6-h sessions [extended-hours haemodialysis (EHD)] may improve patient survival. However, patient characteristics and treatment practices vary between the USA and Europe. We ther

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aef5665d583c8ac3cff404ff8a6c88d
http://hdl.handle.net/2445/172563

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.